An Ascending, Single and Multiple Dose(s), Double-Blind, Randomized, Placebo Controlled Study Assessing the Safety, Tolerability, and Pharmacokinetics of OV329 in Healthy Male and Female Participants
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Ovid Therapeutics
Start Date
December 2, 2022
End Date
June 30, 2025
Administered By
School of Medicine
Awarded By
Ovid Therapeutics
Start Date
December 2, 2022
End Date
June 30, 2025